United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-1528_9611e358-6fe1-4f8d-99a2-250a7862a896
- Product NDC
- 0115-1528
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LAMOTRIGINE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150109
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMOTRIGINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (0115-1528-08) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0115-1528-15) · 0115-1528-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →